Healthcare Sales & Marketing Network News: ProQuin XR

Searching News Database: ProQuin XR

HSMN NewsFeed - 23 Jul 2008
Depomed's ProQuin(R) XR Achieves First Marketing Authorization in Europe
Biopharmaceuticals Regulatory

HSMN NewsFeed - 25 Sep 2007
Depomed and Watson Expand ProQuin(R) XR Promotion Agreement to Include Ob/Gyn Field
Biopharmaceuticals

HSMN NewsFeed - 27 Aug 2007
Dr. John Fara Retires as Chairman, President and CEO of Depomed; Mr. Carl Pelzel Appointed President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Jul 2007
Depomed Reacquires the Rights to ProQuin(R) XR
Biopharmaceuticals Acquisitions Licensing

HSMN NewsFeed - 21 Dec 2006
Depomed Receives $10 Million License Fee from Esprit and Withdraws Arbitration Proceeding
Biopharmaceuticals Licensing Litigation

HSMN NewsFeed - 18 Dec 2006
Depomed Delivers Notice of Breach and Demand for Arbitration to Esprit Pharma
Biopharmaceuticals Drug Delivery Litigation

HSMN NewsFeed - 29 Mar 2006
Depomed and Madaus S.r.l. Announce Acceptance of the Application for Approval of ProQuin(R) XR in Sweden
Biopharmaceuticals Regulatory

Return to NewsFeed

Additional items found! 5

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 5 additional stories matching:
ProQuin XR
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.